Approvals/NMPA/Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)

Approved

生物制品

Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)

玉溪泽润生物技术有限公司🇨🇳 National Medical Products Administration

Approval Id: 8F2ZxtBcS2Q
Approval Number: 国药准字S20220012
Generic Name: 双价人乳头瘤病毒疫苗(毕赤酵母)
Generic Name En: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)
Trade Name: 沃泽惠
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 每瓶0.5ml，含HPV 16型L1蛋白40μg、HPV 18型L1蛋白20μg、磷酸铝佐剂225μg
Reg Date: 2022-03-22
Company Name: 玉溪泽润生物技术有限公司
Company Address: 云南省玉溪市高新区东风南路83号
Production Company Name: 玉溪泽润生物技术有限公司
Production Company Address: 云南省玉溪市高新区东风南路83号1幢整栋、2幢二楼三楼
Company Detail Path: /organization/yu-xi-ze-run-sheng-wu-ji-zhu-you-xian-gong-si
Production Company Detail Path: /organization/yu-xi-ze-run-sheng-wu-ji-zhu-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 22, 2022

Approval ID

8F2ZxtBcS2Q

Type

生物制品